• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸系统综合征冠状病毒 2 变种关注:新兴更具传染性和疫苗抗性菌株的视角。

Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.

机构信息

Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.

Centro de Oncologia Molecular, Hospital Sírio Libanes, São Paulo 01308-060, Brazil.

出版信息

Viruses. 2022 Apr 16;14(4):827. doi: 10.3390/v14040827.

DOI:10.3390/v14040827
PMID:35458557
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9029021/
Abstract

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOC) are constantly threatening global public health. With no end date, the pandemic persists with the emergence of novel variants that threaten the effectiveness of diagnostic tests and vaccines. Mutations in the Spike surface protein of the virus are regularly observed in the new variants, potentializing the emergence of novel viruses with different tropism from the current ones, which may change the severity and symptoms of the disease. Growing evidence has shown that mutations are being selected in favor of variants that are more capable of evading the action of neutralizing antibodies. In this context, the most important factor guiding the evolution of SARS-CoV-2 is its interaction with the host's immune system. Thus, as current vaccines cannot block the transmission of the virus, measures complementary to vaccination, such as the use of masks, hand hygiene, and keeping environments ventilated remain essential to delay the emergence of new variants. Importantly, in addition to the involvement of the immune system in the evolution of the virus, we highlight several chemical parameters that influence the molecular interactions between viruses and host cells during invasion and are also critical tools making novel variants more transmissible. In this review, we dissect the impacts of the Spike mutations on biological parameters such as (1) the increase in Spike binding affinity to hACE2; (2) bound time for the receptor to be cleaved by the proteases; (3) how mutations associate with the increase in RBD up-conformation state in the Spike ectodomain; (4) expansion of uncleaved Spike protein in the virion particles; (5) increment in Spike concentration per virion particles; and (6) evasion of the immune system. These factors play key roles in the fast spreading of SARS-CoV-2 variants of concern, including the Omicron.

摘要

新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的关注变种(VOC)不断威胁着全球公共卫生。由于没有截止日期,随着新变种的出现,这种大流行仍在持续,这些新变种威胁着诊断测试和疫苗的有效性。病毒刺突表面蛋白经常观察到新变种中的突变,可能会产生与当前病毒不同嗜性的新型病毒,这可能会改变疾病的严重程度和症状。越来越多的证据表明,突变正在被选择有利于更能逃避中和抗体作用的变种。在这种情况下,指导 SARS-CoV-2 进化的最重要因素是它与宿主免疫系统的相互作用。因此,由于当前的疫苗不能阻止病毒的传播,接种疫苗以外的措施,如使用口罩、手部卫生和保持环境通风仍然是延迟新变种出现的关键。重要的是,除了免疫系统在病毒进化中的参与外,我们还强调了几个化学参数,这些参数影响病毒和宿主细胞在入侵过程中的分子相互作用,也是使新型变种更具传染性的关键工具。在这篇综述中,我们剖析了 Spike 突变对生物参数的影响,如(1) Spike 与 hACE2 结合亲和力的增加;(2)受体被蛋白酶切割的结合时间;(3)突变如何与 Spike 外域中 RBD 构象状态的增加相关联;(4)未切割 Spike 蛋白在病毒粒子中的扩展;(5)每个病毒粒子中的 Spike 浓度增加;以及(6)逃避免疫系统。这些因素在 SARS-CoV-2 关注变种(包括奥密克戎)的快速传播中发挥着关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/795f9feb9222/viruses-14-00827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/f2faf0446855/viruses-14-00827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/6c62680351e7/viruses-14-00827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/d9b48b6506e1/viruses-14-00827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/795f9feb9222/viruses-14-00827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/f2faf0446855/viruses-14-00827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/6c62680351e7/viruses-14-00827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/d9b48b6506e1/viruses-14-00827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6db1/9029021/795f9feb9222/viruses-14-00827-g004.jpg

相似文献

1
Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Perspective for Emerging More Transmissible and Vaccine-Resistant Strains.严重急性呼吸系统综合征冠状病毒 2 变种关注:新兴更具传染性和疫苗抗性菌株的视角。
Viruses. 2022 Apr 16;14(4):827. doi: 10.3390/v14040827.
2
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
3
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变:对免疫逃逸和疫苗诱导免疫的影响。
Semin Immunol. 2021 Jun;55:101533. doi: 10.1016/j.smim.2021.101533. Epub 2021 Nov 20.
4
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
5
Research progress in spike mutations of SARS-CoV-2 variants and vaccine development.SARS-CoV-2 变异株刺突突变与疫苗研发的研究进展。
Med Res Rev. 2023 Jul;43(4):932-971. doi: 10.1002/med.21941. Epub 2023 Mar 16.
6
Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil.携带接近弗林裂解位点的刺突突变和 N 端结构域缺失的伽马(P.1)亚谱系的传播推动了巴西亚马逊州 SARS-CoV-2 的持续传播。
Microbiol Spectr. 2022 Feb 23;10(1):e0236621. doi: 10.1128/spectrum.02366-21.
7
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.关于关注的 SARS-CoV-2 奥密克戎变异株及其特殊突变特征的最新信息。
Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
8
SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy.SARS-CoV-2 变体增加开放刺突构象的动力学稳定性,这是一种进化策略。
mBio. 2021 Feb 22;13(1):e0322721. doi: 10.1128/mbio.03227-21. Epub 2022 Feb 15.
9
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
10
SARS-CoV-2 variants - Evolution, spike protein, and vaccines.SARS-CoV-2 变体 - 进化、刺突蛋白和疫苗。
Biomed J. 2022 Aug;45(4):573-579. doi: 10.1016/j.bj.2022.04.006. Epub 2022 May 6.

引用本文的文献

1
Antagonistic Trends Between Binding Affinity and Drug-Likeness in SARS-CoV-2 Mpro Inhibitors Revealed by Machine Learning.机器学习揭示的SARS-CoV-2 Mpro抑制剂中结合亲和力与类药性之间的拮抗趋势
Viruses. 2025 Jun 30;17(7):935. doi: 10.3390/v17070935.
2
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies.严重急性呼吸综合征冠状病毒2变种:遗传学见解、流行病学追踪及其对疫苗策略的影响
Int J Mol Sci. 2025 Jan 31;26(3):1263. doi: 10.3390/ijms26031263.
3
A Regional-Scale Assessment-Based SARS-CoV-2 Variants Control Modeling with Implications for Infection Risk Characterization.

本文引用的文献

1
Molecular Dynamics Analysis of Fast-Spreading Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Their Effects on the Interaction with Human Angiotensin-Converting Enzyme 2.快速传播的严重急性呼吸综合征冠状病毒2变种的分子动力学分析及其对与人血管紧张素转换酶2相互作用的影响
ACS Omega. 2022 Aug 25;7(35):30700-30709. doi: 10.1021/acsomega.1c07240. eCollection 2022 Sep 6.
2
Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape.大流行规模的系统发生基因组学揭示了 SARS-CoV-2 的重组景观。
Nature. 2022 Sep;609(7929):994-997. doi: 10.1038/s41586-022-05189-9. Epub 2022 Aug 11.
3
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination.
基于区域尺度评估的SARS-CoV-2变体控制模型及其对感染风险特征描述的意义
Infect Drug Resist. 2024 Oct 31;17:4791-4805. doi: 10.2147/IDR.S480086. eCollection 2024.
4
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.新型冠状病毒 3- 糜蛋白酶样蛋白酶(3CLpro):作为分子靶标的验证、新型催化机制的提出以及临床前和临床试验中的抑制剂。
Viruses. 2024 May 24;16(6):844. doi: 10.3390/v16060844.
5
Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies.新型冠状病毒(SARS-CoV-2)的突变动态:对未来新冠疫苗策略的影响
Heliyon. 2024 Apr 25;10(9):e30208. doi: 10.1016/j.heliyon.2024.e30208. eCollection 2024 May 15.
6
Interrogating the lack of diversity of thought in the pandemic response that led to mistakes - holistic evidence-based approach to deal with future pandemics.探讨导致错误的大流行应对措施中缺乏思想多样性——用整体循证方法应对未来的大流行。
Front Public Health. 2023 Dec 21;11:1310210. doi: 10.3389/fpubh.2023.1310210. eCollection 2023.
7
Low-Entropy Hydration Shells at the Spike RBD's Binding Site May Reveal the Contagiousness of SARS-CoV-2 Variants.刺突蛋白 RBD 结合位点处的低熵水合壳可能揭示 SARS-CoV-2 变体的传染性。
Biomolecules. 2023 Nov 7;13(11):1628. doi: 10.3390/biom13111628.
8
Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest.主要关注和感兴趣的 SARS-CoV-2 变体的基因和蛋白质的定量突变分析。
Viruses. 2023 May 18;15(5):1193. doi: 10.3390/v15051193.
9
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.遗传性 MyD88 和 IRAK-4 缺陷的人类易患低氧血症性 COVID-19 肺炎。
J Exp Med. 2023 May 1;220(5). doi: 10.1084/jem.20220170. Epub 2023 Mar 3.
10
COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany.COVID-19 相关死亡:德国两波疫情间死亡率数据的对比分析。
Infection. 2023 Aug;51(4):1147-1152. doi: 10.1007/s15010-023-01982-4. Epub 2023 Jan 24.
印度的 COVID-19 大流行动态、SARS-CoV-2 德尔塔变异株及其对疫苗接种的影响。
J R Soc Interface. 2022 Jun;19(191):20210900. doi: 10.1098/rsif.2021.0900. Epub 2022 Jun 6.
4
Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant.基于模型对新冠病毒P.1变体的传播性和再感染情况的估计。
Commun Med (Lond). 2021 Nov 15;1:48. doi: 10.1038/s43856-021-00048-6. eCollection 2021.
5
Men are the main COVID-19 transmitters: behavior or biology?男性是新冠病毒的主要传播者:是行为因素还是生物学因素?
Discov Ment Health. 2022;2(1):1. doi: 10.1007/s44192-022-00004-3. Epub 2022 Jan 24.
6
Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant.新冠病毒德尔塔变异株引发的大型溯源清晰的暴发中的病毒感染和传播。
Nat Commun. 2022 Jan 24;13(1):460. doi: 10.1038/s41467-022-28089-y.
7
SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.SARS-CoV-2 奥密克戎变异株:刺突蛋白-ACE2 复合物的抗体逃逸和冷冻电镜结构。
Science. 2022 Feb 18;375(6582):760-764. doi: 10.1126/science.abn7760. Epub 2022 Jan 20.
8
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.广谱中和抗体可克服 SARS-CoV-2 奥密克戎抗原漂移。
Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.
9
Omicron variant and booster COVID-19 vaccines.奥密克戎变种与新冠病毒加强疫苗
Lancet Respir Med. 2022 Feb;10(2):e17. doi: 10.1016/S2213-2600(21)00559-2. Epub 2021 Dec 17.
10
Estimating the transmission advantage of the D614G mutant strain of SARS-CoV-2, December 2019 to June 2020.估算 2019 年 12 月至 2020 年 6 月期间 SARS-CoV-2 的 D614G 突变株的传播优势。
Euro Surveill. 2021 Dec;26(49). doi: 10.2807/1560-7917.ES.2021.26.49.2002005.